Evidence map›Paper›PMID 31659535›Full record

ArticleEJNMMI radiopharmacy and chemistry2019

Ethanol effects on

Michael Meisenheimer, Stefan Kürpig, Markus Essler, Elisabeth Eppard

Open access · goldAbstract read
In one paragraph

Article in EJNMMI radiopharmacy and chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. ScalableWorld journal of nuclear medicine · 2026
    Article
  2. Article
  3. Article
  4. [Pharmaceuticals (Basel, Switzerland) · 2024
    Article
  5. Article
  6. Radiolysis-Associated Decrease in Radiochemical Purity ofMolecules (Basel, Switzerland) · 2023
    Article
  7. Review
  8. Antihormone treatment differentially regulates PSA secretion, PSMA expression andJournal of cancer research and clinical oncology · 2021
    Article
  9. Pharmaceuticals (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Michael MeisenheimerDepartment of Nuclear Medicine, University Hospital Bonn, Venusberg-Campus 1, Building 21, 53127, Bonn, Germany.
Stefan KürpigDepartment of Nuclear Medicine, University Hospital Bonn, Venusberg-Campus 1, Building 21, 53127, Bonn, Germany.
Markus EsslerDepartment of Nuclear Medicine, University Hospital Bonn, Venusberg-Campus 1, Building 21, 53127, Bonn, Germany.
Elisabeth EppardPositronPharma S.A, Rancagua 878, 7500921, Providencia, Chile. eeppard@positronpharma.cl.ORCID http://orcid.org/0000-0002-4400-2070
University Hospital Bonn · DEItron (United States) · US

Funding

Bonfor O-140.0008
6 · The paper itself

Abstract

objectiveRecent studies showed that ethanol in the reaction mixture improves radiolabelling with trivalent radiometals in terms of precursor amount, reaction time, reaction temperature and radiolysis. With regard to clinical application, this effect is of practical interest in radiopharmacy. The aim of this study was to evaluate whether the positive effect of ethanol can be exploited in automated systems utilizing NaCl-post processing.

methodsGallium-68 was obtained from a 1.85 GBq

resultsUtilization of additional ethanol on an automated cassette module can be achieved by adding ethanol directly to the buffer solution without further modifications of the standard procedure. Radiolysis was decreased significantly as analysed by radioHPLC.

conclusionIt was possible to combine the positive effects of ethanol on radiolabelling efficacy and radiolysis with the standard labelling procedure of an automated cassette module system. The whole process guarantees safe preparation of highly pure

Indexed as

EthanolGallium-68Module systemQuality controlRadiolabelling yieldRadiolysis

Identifiers

PMID31659535
PMCPMC6779680
OpenAlexW2980306683

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.